MBX BIOSCIENCES, INC.
Last · NASDAQ$48.82-0.18 (-0.37%)close · yahoo · 16h ago
Vol 994.4K ≈ 48.55M
MA10MA20MA50
Market cap$2.35B48.2M sh
P/E · TTM-20.6fwd -12.3 · eps -2.37 · loss
Beta0.10vs S&P 500
Div yield0.00%annual · TTM
52w range
$12.94$72.64
Volume994.4Ksession
Issuer
Legal nameMBX BIOSCIENCES, INC.
HQUnited States (US)
ListingUS MBX
ISINUS55287L1017
SectorHealthcare
IndustryDrugs (Pharmaceutical)
SIC2834
CurrencyUSD
Entity registrysec:0001776111
CIK0001776111
Websitewww.mbxbio.com
Employees63
AddressMBX Biosciences, Inc. 11711 North Meridian Street 46032, Carmel
Loading chart…
Upcoming earnings
THU.5NOV
1:30 PM UTC+1
Period
Sep 2026
Est. EPS
−$0.84
Est. revenue
0
Press & signals
- GlobeNewswire
MBX Biosciences Announces Appointment of Jeff Held as Chief Legal Officer
- GlobeNewswire
MBX Biosciences Reports Second Quarter 2026 Financial Results and Corporate Highlights
- GlobeNewswire
MBX Biosciences Announces Executive Leadership Transition to Support the Company’s Next Phase of Growth
Documents
FormReporting forFiledFlags
Showing 4 of 4 filings